BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 11, 2011, Pages 1641-1651

  Hmeljak, Julija ^a   Erčulj, Nina ^b   Dolžan, Vita ^b   Kern, Izidor ^c   Cör, Andrej ^a  

^a UNIVERSITY OF PRIMORSKA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c University Clinic of Pulmonary and Allergic Diseases Golnik   (Slovenia)

Author keywords

Genotyping; Immunohistochemistry; Mesothelioma; Survival analysis; Survivin

Indexed keywords

ASBESTOS; SURVIVIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIRC5 GENE; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; DNA EXTRACTION; ENVIRONMENTAL EXPOSURE; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL;

CELL NUCLEUS; GENOTYPE; HAPLOTYPES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MESOTHELIOMA; PLEURAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SURVIVAL ANALYSIS;

EID: 80054738926     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1030-0     Document Type: Article

References (51)

1. AG Antonacopoulou K Floratou V Bravou A Kottorou FI Dimitrakopoulos S Marousi M Stavropoulos AK Koutras CD Scopa HP Kalofonos 2010 The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival Anal Cell Pathol (Amst) 33 5 177 189 1:CAS:528:DC%2BC3MXovVymsQ%3D%3D
2. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2 263 265 15297300 10.1093/bioinformatics/bth457 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D (Pubitemid 40202029)
3. C Boutin F Rey J Gouvernet JR Viallat P Astoul V Ledoray 1993 Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: prognosis and staging Cancer 72 2 394 404 8319171 10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5 1:STN:280:DyaK3szgs1GrsA%3D%3D (Pubitemid 23193444)
4. Cancer in Slovenia 2007 (2010) Cancer in Slovenia (trans: Registry EaC). Institute of Oncology, Ljubljana
5. P Canedo G Corso F Pereira N Lunet G Suriano C Figueiredo C Pedrazzani H Moreira H Barros F Carneiro R Seruca F Roviello JC Machado 2008 The interferon gamma receptor 1 (IFNGR1)-56C/T gene polymorphism is associated with increased risk of early gastric carcinoma Gut 57 11 1504 1508 18593809 10.1136/gut.2007.143578 1:CAS:528:DC%2BD1cXhtl2gtr7J
6. M Carbone SM Albelda VC Broaddus RM Flores G Hillerdal MC Jaurand K Kjaerheim HI Pass B Robinson A Tsao 2007 Eighth international mesothelioma interest group Oncogene 26 49 6959 6967 17496929 10.1038/sj.onc.1210515 1:CAS:528:DC%2BD2sXht1Wgt7rO (Pubitemid 350014615)
7. M Casparie AT Tiebosch G Burger H Blauwgeers A van de Pol JH van Krieken GA Meijer 2007 Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive Cell Oncol 29 1 19 24 17429138 1:STN:280: DC%2BD2s3itVeitw%3D%3D (Pubitemid 46535194)
8. Churg A, Roggli VL, Galateau-Salle F, Cagle PT, Gibbs AR, Hasleton PS, Henderson DW, Vignaud JM, Inai K, Praet M, Ordonez NG, Hammar SP, Testa JR, Gazdar AF, Saracci R, Pugatch R, Samet JM, Weill H, Rusch V, Colby TV, Vogt P, Brambilla E, Travis WD (2004) Mesothelioma. In: Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC (eds) Pathology and genetics of tumours of the lung, pleura, thymus and heart, vol 10. WHO classification of tumours. WHO Press, Geneva, pp 128-136
9. M Debevec V Kovač A Debeljak J Eržen Z Remškar I Kern 2000 Maligni plevralni mezoteliom, analiza bolnikov v Sloveniji 1980-1997 (Malignant pleural mesothelioma. analysis of patients in Slovenia 1980-1997) Zdrav Vest 69 599 606
10. T Dohi F Xia DC Altieri 2007 Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection Mol Cell 27 1 17 28 17612487 10.1016/j.molcel.2007.06.004 1:CAS:528:DC%2BD2sXot1els7w%3D (Pubitemid 46991388)
11. JG Edwards KR Abrams JN Leverment TJ Spyt DA Waller KJ O'Byrne 2000 Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems Thorax 55 9 731 735 10950889 10.1136/thorax.55.9.731 1:STN:280:DC%2BD3cvmtVOkug%3D%3D (Pubitemid 30660898)
12. S El Hallani F Ducray A Idbaih Y Marie B Boisselier C Colin F Laigle-Donadey M Rodero O Chinot J Thillet K Hoang-Xuan JY Delattre M Sanson 2009 TP53 codon 72 polymorphism is associated with age at onset of glioblastoma Neurology 72 4 332 336 19171829 10.1212/01.wnl.0000341277.74885.ec 1:CAS:528:DC%2BD1MXmvVKhtg%3D%3D
13. P Fortugno NR Wall A Giodini DS O'Connor J Plescia KM Padgett S Tognin PC Marchisio DC Altieri 2002 Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function J Cell Sci 115 Pt 3 575 585 11861764 1:CAS:528:DC%2BD38XitVWmurg%3D (Pubitemid 34182984)
14. M Gazouli N Tzanakis G Rallis G Theodoropoulos I Papaconstantinou A Kostakis N Anagnou N Nikiteas 2009 Survivin-31G/C promoter polymorphism and sporadic colorectal cancer Int J Colorectal Dis 24 2 145 150 18946675 10.1007/s00384-008-0601-2
15. GJ Gordon M Mani L Mukhopadhyay L Dong HR Edenfield JN Glickman BY Yeap DJ Sugarbaker R Bueno 2007 Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma J Pathol 211 4 447 454 17253596 10.1002/path.2121 1:CAS:528:DC%2BD2sXjs1yrs7g%3D (Pubitemid 46332556)
16. CH Han Q Wei KK Lu Z Liu GB Mills LE Wang 2009 Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer Int J Clin Exp Med 2 4 289 299 20057973 1:CAS:528:DC%2BD1MXhsVOgur3L
17. J Hmeljak A Cor 2009 Presence and role of Simian Virus 40 (SV40) in malignant pleural mesothelioma Radiol Oncol 43 1 9 16 10.2478/v10019-009-0009-9 1:CAS:528:DC%2BD1MXltVWgtrw%3D
18. JS Jang KM Kim KH Kang JE Choi WK Lee CH Kim YM Kang S Kam IS Kim JE Jun TH Jung JY Park 2008 Polymorphisms in the survivin gene and the risk of lung cancer Lung Cancer J Iaslc 60 1 31 39 10.1016/j.lungcan.2007.09.008 (Pubitemid 351434465)
19. R Kannangai J Wang QZ Liu F Sahin M Torbenson 2005 Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation Int J Gastrointest Cancer 35 1 53 60 15722574 10.1385/IJGC:35:1:053 1:CAS:528:DC%2BD2MXivFKhurw%3D (Pubitemid 40458580)
20. KW Kim RW Mutter CD Willey TK Subhawong ET Shinohara JM Albert G Ling C Cao YJ Gi B Lu 2007 Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests Int J Radiat Oncol 67 5 1519 1525 10.1016/j.ijrobp.2006.12.018 1:CAS:528:DC%2BD2sXjs1Oju7c%3D (Pubitemid 46467182)
21. L Kleinberg AK Lie VA Florenes JM Nesland B Davidson 2007 Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma Hum Pathol 38 7 986 994 17350081 10.1016/j.humpath.2006.12.013 1:CAS:528: DC%2BD2sXmsFylt7g%3D (Pubitemid 46899149)
22. L Kren J Brazdil M Hermanova VN Goncharuk BV Kallakury P Kaur JS Ross 2004 Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases Appl Immunohistochem Mol Morphol 12 1 44 49 15163019 1:CAS:528:DC%2BD2cXivFGrtbw%3D (Pubitemid 38332319)
23. Y Lei Z Geng W Guo-Jun W He Y Jian-Lin 2010 Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance Mol Cell Biochem 344 1-2 23 31 20563741 10.1007/s11010-010-0525- 3
24. FZ Li DC Altieri 1999 Transcriptional analysis of human survivin gene expression Biochem J 344 305 311 10567210 10.1042/0264-6021:3440305 1:CAS:528:DC%2BD3cXltFGj (Pubitemid 30011584)
25. FZ Li G Ambrosini EY Chu J Plescia S Tognin PC Marchisio DC Altieri 1998 Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 6711 580 584 9859993 10.1038/25141 1:CAS:528:DyaK1cXotVWns70%3D (Pubitemid 28563719)
26. AN Ma WL Huang ZN Wu JF Hu T Li XJ Zhou YX Wang 2010 Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth Biochem Biophys Res Commun 393 4 592 597 20152814 10.1016/j.bbrc.2010.02. 020 1:CAS:528:DC%2BC3cXjs1Onsbk%3D
27. AN Ma J Lu XJ Zhou YX Wang 2011 Histone deacetylation directs DNA methylation in survivin gene silencing Biochem Biophys Res Commun 404 1 268 272 21130077 10.1016/j.bbrc.2010.11.105 1:CAS:528:DC%2BC3MXksFyjug%3D%3D
28. Marsh S (2009) Concordance between tumor and germline DNA. In: Innocenti F (ed) Cancer drug discovery and development: genomics and pharmacogenomis in anticancer drug development and clinical response. Humana Press, Totowa, pp 91-101
29. AJ Moore RJ Parker J Wiggins 2008 Malignant mesothelioma Orphanet J Rare Dis 3 34 19099560 10.1186/1750-1172-3-34
30. B Nachmias Y Ashhab D Ben-Yehuda 2004 The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer Semin Cancer Biol 14 4 231 243 15219616 10.1016/j.semcancer.2004.04.002 1:CAS:528:DC%2BD2cXlt1agurY%3D (Pubitemid 38824584)
31. S Nojiri K Gemba K Aoe K Kato T Yamaguchi T Sato K Kubota T Kishimoto 2011 Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan Jpn J Clin Oncol 41 1 32 39 20798232 10.1093/jjco/hyq159
32. Pizem J, Cor A (2003) Survivin-an inhibitor of apoptosis and a new target in cancer. Radiol Oncol 37(3):195-202
33. J Pizem A Cor L Zadravec-Zaletel M Popovic 2005 Survivin is a negative prognostic marker in medulloblastoma Neuropathol Appl Neurobiol 31 4 422 428 16008826 10.1111/j.1365-2990.2005.00664.x 1:CAS:528:DC%2BD2MXpslWisr0%3D (Pubitemid 41059863)
34. J Pizem A Cor LZ Zaletel M Popovic 2005 Prognostic significance of apoptosis in medulloblastoma Neurosci Lett 381 1-2 69 73 15882792 10.1016/j.neulet.2005.02.021 1:CAS:528:DC%2BD2MXktVOlsL4%3D (Pubitemid 40693144)
35. JM Rae KE Cordero JO Scheys ME Lippman DA Flockhart MD Johnson 2003 Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples Pharmacogenetics 13 8 501 507 12893988 10.1097/00008571-200308000-00008 1:CAS:528:DC%2BD3sXlvV2jtL4%3D (Pubitemid 37034592)
36. BW Robinson 2009 Mesothelioma biomarkers: what do we know and how do we use them? J Thorac Oncol 4 9 S207 S208
37. AI Sarela RC Macadam SM Farmery AF Markham PJ Guillou 2000 Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma Gut 46 5 645 650 10764707 10.1136/gut.46.5.645 1:CAS:528: DC%2BD3cXjsVShu7Y%3D (Pubitemid 30305781)
38. ST Sherry MH Ward M Kholodov J Baker L Phan EM Smigielski K Sirotkin 2001 dbSNP: the NCBI database of genetic variation Nucleic Acids Res 29 1 308 311 11125122 10.1093/nar/29.1.308 1:CAS:528:DC%2BD3MXjtlWmtb0%3D (Pubitemid 32054478)
39. RH Stauber W Mann SK Knauer 2007 Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential Cancer Res 67 13 5999 6002 17616652 10.1158/0008-5472.CAN-07-0494 1:CAS:528:DC%2BD2sXnsVyqsL8%3D (Pubitemid 47037475)
40. LA Stephens NG Powell J Grubb SJ Jeremiah JA Bethel EP Demidchik TI Bogdanova MD Tronko GA Thomas 2005 Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma Thyroid 15 2 100 104 15753666 10.1089/thy.2005.15.100 1:CAS:528:DC%2BD2MXitVyqtro%3D (Pubitemid 40344355)
41. L Su Y Wang M Xiao Y Lin L Yu 2010 Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110 4 484 491 20868995 10.1016/j.tripleo.2010.04.009
42. The International HapMap C 2005 A haplotype map of the human genome Nature 437 7063 1299 1320 10.1038/nature04226 (Pubitemid 41568671)
43. B Thyagarajan KE Anderson F Kong FR Selk CF Lynch MD Gross 2005 New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study J Clin Pathol 58 9 955 961 16126877 10.1136/jcp.2004.023374 1:CAS:528:DC%2BD2MXhtFSks7fE (Pubitemid 41265281)
44. DA Tregouet V Garelle 2007 A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies Bioinformatics 23 8 1038 1039 17308338 10.1093/bioinformatics/btm058 1:CAS:528:DC%2BD2sXmtVKqtbs%3D (Pubitemid 47050595)
45. M Uematsu I Ohsawa T Aokage K Nishimaki K Matsumoto H Takahashi S Asoh A Teramoto S Ohta 2005 Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index J Neuro Oncol 72 3 231 238 10.1007/s11060-004-2353-3 1:CAS:528:DC%2BD28XltA%3D%3D (Pubitemid 40867405)
46. R Upadhyay R Khurana S Kumar U Ghoshal B Mittal 2011 Role of survivin gene promoter polymorphism (-31G > C) in susceptibility and survival of esophageal cancer in northern India Ann Surg Oncol 18 3 880 887 20957442 10.1245/s10434-010-1371-y
47. M Wagner K Schmelz B Dorken I Tamm 2008 Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia Leuk Res 32 7 1054 1060 18206228 10.1016/j.leukres.2007.11.013 1:CAS:528:DC%2BD1cXkvFWkt70%3D
48. RA Walker 2006 Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I Histopathology 49 4 406 410 16978204 10.1111/j.1365-2559.2006.02514.x 1:STN:280:DC%2BD28rlsVSktA%3D%3D (Pubitemid 44401548)
49. Y Xu F Fang G Ludewig G Jones D Jones 2004 A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells DNA Cell Biol 23 7 419 429 15294091 10.1089/1044549041474788 1:CAS:528:DC%2BD2cXlvVOlur8%3D (Pubitemid 38981976)
50. XY Yang G Xiong XD Chen XQ Xu K Wang Y Fu K Yang Y Bai 2009 Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma J Cancer Res Clin Oncol 135 10 1341 1349 19352701 10.1007/s00432-009- 0575-7 1:CAS:528:DC%2BD1MXhtVSitL7K
51. ZB Zhu SK Makhija BG Lu MH Wang SY Wang K Takayama GP Siegal PN Reynolds DT Curiel 2006 Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses J Thorac Oncol 1 7 701 711 17409940 10.1097/01243894-200609000-00017 (Pubitemid 47163960)